CD274 and breast carcinoma: PD-1 and PD-L1 expression has been described in patients with cancers of the liver [37], bladder [38], colon [39], cervix [40], ovary [41], and breast [42], and the expression of this molecule can serve as a reliable predictor for gastric, esophageal, and breast cancer [43].